Axa’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.8M Sell
360,320
-211,851
-37% -$11.6M 0.06% 284
2025
Q1
$40.4M Buy
572,171
+633
+0.1% +$44.7K 0.13% 159
2024
Q4
$37.6M Buy
571,538
+8,874
+2% +$583K 0.11% 172
2024
Q3
$39.5M Sell
562,664
-10,407
-2% -$732K 0.12% 177
2024
Q2
$47.2M Buy
573,071
+168,620
+42% +$13.9M 0.14% 150
2024
Q1
$35.3M Buy
404,451
+48,759
+14% +$4.26M 0.11% 191
2023
Q4
$34.3M Sell
355,692
-7,656
-2% -$738K 0.11% 190
2023
Q3
$32.1M Sell
363,348
-22,937
-6% -$2.03M 0.11% 189
2023
Q2
$33.5M Buy
386,285
+1,309
+0.3% +$113K 0.11% 205
2023
Q1
$37.4M Sell
384,976
-22,253
-5% -$2.16M 0.13% 189
2022
Q4
$42.1M Sell
407,229
-164,367
-29% -$17M 0.15% 162
2022
Q3
$48.5M Sell
571,596
-46,391
-8% -$3.93M 0.19% 126
2022
Q2
$51.2M Buy
617,987
+189,380
+44% +$15.7M 0.19% 127
2022
Q1
$33M Sell
428,607
-2,991
-0.7% -$231K 0.09% 246
2021
Q4
$38.1M Buy
431,598
+31,841
+8% +$2.81M 0.1% 234
2021
Q3
$30.9M Buy
399,757
+115,951
+41% +$8.96M 0.09% 259
2021
Q2
$23.7M Sell
283,806
-40,293
-12% -$3.36M 0.07% 310
2021
Q1
$24.5M Sell
324,099
-51,794
-14% -$3.91M 0.07% 306
2020
Q4
$33M Buy
375,893
+10,891
+3% +$955K 0.1% 222
2020
Q3
$27.8M Sell
365,002
-81,035
-18% -$6.17M 0.1% 232
2020
Q2
$55M Buy
446,037
+136,717
+44% +$16.9M 0.22% 110
2020
Q1
$26.1M Sell
309,320
-72,046
-19% -$6.09M 0.13% 186
2019
Q4
$32.2M Sell
381,366
-5,878
-2% -$497K 0.13% 199
2019
Q3
$26.1M Buy
387,244
+51,384
+15% +$3.46M 0.1% 247
2019
Q2
$28.8M Buy
335,860
+3,433
+1% +$294K 0.11% 240
2019
Q1
$29.5M Sell
332,427
-32,750
-9% -$2.91M 0.12% 227
2018
Q4
$31.1M Sell
365,177
-102
-0% -$8.69K 0.14% 203
2018
Q3
$35.4M Sell
365,279
-51,962
-12% -$5.04M 0.13% 207
2018
Q2
$39.3M Buy
417,241
+36,840
+10% +$3.47M 0.15% 182
2018
Q1
$30.8M Sell
380,401
-4,234
-1% -$343K 0.12% 203
2017
Q4
$34.3M Sell
384,635
-231
-0.1% -$20.6K 0.13% 207
2017
Q3
$35.8M Sell
384,866
-17,391
-4% -$1.62M 0.15% 191
2017
Q2
$36.5M Sell
402,257
-10,730
-3% -$974K 0.17% 175
2017
Q1
$36.3M Sell
412,987
-7,862
-2% -$690K 0.16% 179
2016
Q4
$34.9M Buy
420,849
+25,809
+7% +$2.14M 0.16% 171
2016
Q3
$36.5M Sell
395,040
-68,727
-15% -$6.36M 0.16% 176
2016
Q2
$36.1M Sell
463,767
-7,107
-2% -$553K 0.16% 174
2016
Q1
$38.8M Buy
470,874
+45,781
+11% +$3.78M 0.17% 162
2015
Q4
$44.5M Sell
425,093
-37,146
-8% -$3.89M 0.19% 153
2015
Q3
$48.7M Sell
462,239
-3,479
-0.7% -$366K 0.2% 142
2015
Q2
$63.7M Buy
465,718
+1,655
+0.4% +$226K 0.26% 112
2015
Q1
$57.8M Buy
464,063
+36,977
+9% +$4.61M 0.24% 122
2014
Q4
$38.6M Sell
427,086
-7,019
-2% -$635K 0.15% 172
2014
Q3
$31.3M Buy
434,105
+18,948
+5% +$1.37M 0.13% 197
2014
Q2
$25.8M Buy
415,157
+14,508
+4% +$903K 0.11% 220
2014
Q1
$27.3M Buy
400,649
+30,565
+8% +$2.08M 0.12% 200
2013
Q4
$26M Buy
370,084
+171,292
+86% +$12M 0.12% 206
2013
Q3
$14.4M Buy
198,792
+3,394
+2% +$245K 0.07% 283
2013
Q2
$10.9M Buy
+195,398
New +$10.9M 0.06% 321